← Evidence map

ReviewHuman vaccines & immunotherapeutics2026

Engineered nanovaccines for prophylactic and therapeutic immunotherapy against cancer and infectious disease.

Muhammad Inam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42826091